Chloroquine in fighting COVID-19: good, bad, or both?

Daolin Tang, Jingbo Li, Ruoxi Zhang, Rui Kang, Daniel J. Klionsky

Research output: Contribution to journalArticle

1 Scopus citations


Coronavirus disease 2019 (COVID-19) has attracted worldwide attention due to its speed of progression and elevated mortality rate. Amid the rush to develop treatments, recent hopes have focused on the anti-malarial drug chloroquine or the derivative hydroxychloroquine. Here, we briefly discuss the evidence for the potential use of these drugs with regard to the current pandemic.

Original languageEnglish (US)
StateAccepted/In press - 2020


  • autophagy
  • Chloroquine
  • clinical trial
  • COVID-19
  • hydroxychloroquine
  • SARS-CoV-2

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Chloroquine in fighting COVID-19: good, bad, or both?'. Together they form a unique fingerprint.

  • Cite this